Free Trial

Sensei Biotherapeutics (SNSE) Earnings Date, Estimates & Call Transcripts

Sensei Biotherapeutics logo
$0.36 -0.02 (-4.41%)
As of 05/9/2025 04:00 PM Eastern

Sensei Biotherapeutics Earnings Summary

Sensei Biotherapeutics issued Q1 2025 earnings on May 6, 2025, reporting an EPS of -$0.27, which missed analysts' consensus estimates of -$0.21 by $0.06. With a trailing EPS of -$1.15, Sensei Biotherapeutics' earnings are expected to grow next year, from ($1.17) to ($0.63) per share.

Latest Q1
Earnings Date
May. 6Estimated
Consensus EPS
(May. 6)
-$0.21
Actual EPS
(May. 6)
-$0.27 Missed By -$0.06

Q1 2025 Earnings Resources

Get Sensei Biotherapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Sensei Biotherapeutics and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

SNSE Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Sensei Biotherapeutics Analyst EPS Estimates

Current Year EPS Consensus Estimate
($1.17) EPS
Next Year EPS Consensus Estimate
($0.63) EPS

Sensei Biotherapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/6/2025Q1 2025-$0.21-$0.27 -$0.06-$0.27--
3/28/2025Q4 2024-$0.27-$0.27--$0.31--
8/6/2024Q2 2024-$0.29-$0.28+$0.01-$0.28--
5/9/2024Q1 2024-$0.29-$0.32 -$0.03-$0.32--
2/28/2024Q4 2023-$0.32-$0.30+$0.02-$0.30--
11/7/2023Q3 2023-$0.28-$0.28--$0.28--
8/3/2023Q2 2023-$0.32-$0.31+$0.01-$0.31--

Sensei Biotherapeutics Earnings - Frequently Asked Questions

Sensei Biotherapeutics (NASDAQ:SNSE) last announced its quarterly earning data on Tuesday, May 6, 2025. Learn more on SNSE's earnings history.

In the previous quarter, Sensei Biotherapeutics (NASDAQ:SNSE) missed the analysts' consensus estimate of ($0.21) by $0.06 with a reported earnings per share (EPS) of ($0.27). Learn more on analysts' earnings estimate vs. SNSE's actual earnings.

Sensei Biotherapeutics (NASDAQ:SNSE) has a recorded net income of -$34.10 million. SNSE has generated -$1.15 earnings per share over the last four quarters.

Sensei Biotherapeutics's earnings are expected to grow from ($1.17) per share to ($0.63) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:SNSE) was last updated on 5/11/2025 by MarketBeat.com Staff
From Our Partners